Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 301 AL 315

Alzheimer's in 3D culture: challenges and perspectives

D'Avanzo C, Aronson J, Kim YH, Choi SH, Tanzi RE, Kim DY.

Bioessays. 2015 Oct;37(10):1139-48. doi: 10.1002/bies.201500063. Epub 2015 Aug 7.

Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease

Zhang FF, Li J.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7640-3. eCollection 2015.

Testing a modified perceived exertion scale for Alzheimer's disease

Yu F, Demorest SL, Vock DM.

Psych J. 2015 Mar;4(1):38-46. doi: 10.1002/pchj.82. Epub 2015 Jan 30.

From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease

Pérez DI, Martínez A, Gil C, Campillo NE.

Curr Med Chem. 2015;22(33):3789-806. doi: 10.2174/0929867322666150812145825.

Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease

Rozpedek W, Markiewicz L, Diehl JA, Pytel D, Majsterek I.

Curr Med Chem. 2015;22(27):3169-84. doi: 10.2174/0929867322666150818104254.

The preclinical phase of the pathological process underlying sporadic Alzheimer's disease

Braak H, Del Tredici K.

Brain. 2015 Oct;138(Pt 10):2814-33. doi: 10.1093/brain/awv236. Epub 2015 Aug 17.

Editorial transition at Alzheimer's Disease and Associated Disorders

Luchsinger JA.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):183. doi: 10.1097/WAD.0000000000000106.

Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents

Shadfar S, Hwang CJ, Lim MS, Choi DY, Hong JT.

Arch Pharm Res. 2015 Dec;38(12):2106-19. doi: 10.1007/s12272-015-0648-x. Epub 2015 Aug 21.

Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis

Su J, Liu Y, Liu Y, Ren L.

Expert Rev Neurother. 2015;15(9):1093-103. doi: 10.1586/14737175.2015.1068120. Epub 2015 Aug 6.

Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease

Anand K, Sabbagh M.

Expert Opin Investig Drugs. 2015;24(10):1355-60. doi: 10.1517/13543784.2015.1075002. Epub 2015 Aug 1.

CT-based attenuation and scatter correction compared with uniform attenuation correction in brain perfusion SPECT imaging for dementia

Gillen R, Firbank MJ, Lloyd J, O'Brien JT.

Phys Med Biol. 2015 Sep 7;60(17):6775-87. doi: 10.1088/0031-9155/60/17/6775. Epub 2015 Aug 21.

The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia

Luca M, Luca A, Calandra C.

Oxid Med Cell Longev. 2015;2015:504678. doi: 10.1155/2015/504678. Epub 2015 Aug 2.

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease

Thomas J, Thomas CJ, Radcliffe J, Itsiopoulos C.

Biomed Res Int. 2015;2015:172801. doi: 10.1155/2015/172801. Epub 2015 Aug 2.

Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease

Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH.

JAMA Neurol. 2015 Oct;72(10):1139-47. doi: 10.1001/jamaneurol.2015.1807.

Neuropsychiatric Symptoms, Caregiver Burden and Distress in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease

Lima-Silva TB, Bahia VS, Carvalho VA, Guimarães HC, Caramelli P, Balthazar ML, Damasceno B, Bottino CM, Brucki SM, Nitrini R, Yassuda MS.

Dement Geriatr Cogn Disord. 2015;40(5-6):268-75. doi: 10.1159/000437351. Epub 2015 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias